Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Jon Arfstrom
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 14on tracked calls
- Challenge rate
- 0%none of 14 questions
- Companies
- 1questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 14 of 14 questions from 1 company
HBANHuntington Bancshares14 questions · 7 reporting periods · 0 of 14 challenging
Calendar 2026 Q2
can you talk a little bit more about your confidence in the higher end of that or above and what's driving it?
Show response
Zach cited fee organic growth accelerating from 18% to 30% YoY, driven by payments, wealth, and capital markets investment.
Maybe the growth was a little slower this quarter, in terms of the organic growth.
Show response
Steinour attributed slower loan growth to a deliberate ~$2 billion indirect-auto pullback on return discipline, calling it temporary.
Calendar 2026 Q1
can you talk a little bit more about the balance sheet optimization project, just kind of why you're pursuing it, the overall goal
Show response
Zach explained they're calibrating to softer macro outlook, reducing CRE construction exposure, and matching loan growth with core deposit growth to manage NIM.
the $3 billion buyback authorization. Why that size? What's the plan for utilizing that?
Show response
Zach cited industry best practice for evergreen authorization, noted $1.1-1.2B planned over 2 years already, and highlighted Basel III as additional opportunity in 2027.
Calendar 2025 Q4
anything you can do to give us a little tighter range on expected first-quarter expenses or early '26 expenses just to help set this up
Show response
Zach declined to provide quarterly expense guidance, redirecting to operating leverage framework of 100-200bp annually. Highlighted Cadence marginal profitability at 50% efficiency ratio even before full cost synergies.
How material are those? And then what revenue synergies, if any, from Veritex and Cadence is included in the guide
Show response
Zach confirmed very little revenue synergies in 2026 guidance. Deep dive on revenue synergy expectations planned for later in Q1. Five consecutive years of ~20% investment growth into business continuing. Key focus: digital technology, marketing acquisition, people to build businesses.
Calendar 2025 Q3
can you talk a little bit more about what you're seeing from a credit quality point of view? There's obviously a lot of fear and uncertainty out there
Show response
Steve attributed strong credit to 15-year aggregate moderate-to-low risk appetite. Consumer and commercial portfolios equally tight. Brendan confirmed no current concerns. Stress test track record reinforces confidence.
Can you talk a little bit more about the pipelines Zach, you mentioned you felt like growth is still accelerating. And I guess, I'm not as curious about the expansion driven markets, but more about...
Show response
Zach confirmed accelerating momentum with Q4 guidance implying approximately 1.5% sequential growth. Regional banking, commercial specialty, equipment and asset finance, and consumer auto all contributing. Working assumption for 2026 is mid to high single digit loan growth.
Calendar 2025 Q2
It feels like you have enough momentum to hit the higher end of that range. But curious in your mind what you see as the threats
Show response
Zach confirmed high end achievable, citing loan growth momentum and stable NIM outlook. Main risk is economic stability, which does not appear to be reverting.
can you give us some of the feedback you've heard maybe pro and cons from internal and external partners on the Veritex acquisition
Show response
Steve described strong long-shareholder support. Brant confirmed Veritex colleagues and customers excited about expanded capabilities and local structure.
Calendar 2025 Q1
non-interest income guide for modest growth sequentially. It looks like in your materials, you're pointing to the year-over-year growth rates
Show response
Zach noted 11% YoY fee growth in key areas in line with Investor Day targets. M&A advisory timing is biggest put/take for top vs bottom of 4-6% fee range.
where are you the most focused right now in terms of risk management? Obviously, a strong record historically on risk
Show response
Steve described broad-based portfolio management with active customer outreach. Constructive view of supporting customers through challenges. No one particular portfolio of unique focus.
Calendar 2024 Q4
Can you talk a little bit about the borrower feedback that you're hearing over the last few months?
Show response
Steve shared that nearly 100% of roughly 100 customer/prospect meetings post-election were positive on 2025 outlook, with consensus of expected growth and increased inventories.
with the new administration coming in and some changes in the regulatory leadership, what regulatory changes would you like to see
Show response
Steve expected Basel III overhang to be addressed quickly, more stability on capital and liquidity requirements, and constructive regulatory dialogue.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| HBAN Huntington Bancshares | 14 | 0%none of 14 questions |
- HBANHuntington Bancshares · 14 questions0%none of 14 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 2 | 0%none of 2 questions | 1 |
| 2025 Q1 | 2 | 0%none of 2 questions | 1 |
| 2025 Q2 | 2 | 0%none of 2 questions | 1 |
| 2025 Q3 | 2 | 0%none of 2 questions | 1 |
| 2025 Q4 | 2 | 0%none of 2 questions | 1 |
| 2026 Q1 | 2 | 0%none of 2 questions | 1 |
| 2026 Q2 | 2 | 0%none of 2 questions | 1 |
- 2024 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q22 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2026 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2026 Q22 questions · challenge rate 0% (none of 2 questions) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Revenue Growth4
- Demand3
- Margin3
- Capital Allocation2
- M&A2
- Credit2
- Guidance Reliability2
- Macroeconomic2
- Competitive Dynamics1
- Regulation Policy1